These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 35448891)

  • 1. Botulinum Toxin Therapy for Oromandibular Dystonia and Other Movement Disorders in the Stomatognathic System.
    Yoshida K
    Toxins (Basel); 2022 Apr; 14(4):. PubMed ID: 35448891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum Toxin in Movement Disorders: An Update.
    Anandan C; Jankovic J
    Toxins (Basel); 2021 Jan; 13(1):. PubMed ID: 33430071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update on new and unique uses of botulinum toxin in movement disorders.
    Jankovic J
    Toxicon; 2018 Jun; 147():84-88. PubMed ID: 28888928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurophysiological Basis of Deep Brain Stimulation and Botulinum Neurotoxin Injection for Treating Oromandibular Dystonia.
    Maezawa H; Hirata M; Yoshida K
    Toxins (Basel); 2022 Nov; 14(11):. PubMed ID: 36356002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment strategies for dystonia.
    Cloud LJ; Jinnah HA
    Expert Opin Pharmacother; 2010 Jan; 11(1):5-15. PubMed ID: 20001425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin for motor disorders.
    Safarpour D; Jabbari B
    Handb Clin Neurol; 2023; 196():539-555. PubMed ID: 37620089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Botulinum Toxin Therapy on Health-Related Quality of Life Evaluated by the Oromandibular Dystonia Rating Scale.
    Yoshida K
    Toxins (Basel); 2022 Sep; 14(10):. PubMed ID: 36287925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Botulinum Toxin Type A on Pain among Trigeminal Neuralgia, Myofascial Temporomandibular Disorders, and Oromandibular Dystonia.
    Yoshida K
    Toxins (Basel); 2021 Aug; 13(9):. PubMed ID: 34564609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum Toxin, a Drug with Potential Interest for Dentists-An Introduction.
    Bakke M
    Toxins (Basel); 2022 Sep; 14(10):. PubMed ID: 36287936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin in movement disorders.
    Tater P; Pandey S
    Neurol India; 2018; 66(Supplement):S79-S89. PubMed ID: 29503330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias.
    Rosales RL; Ng AR; Santos MM; Fernandez HH
    Int J Neurosci; 2011; 121 Suppl 1():44-56. PubMed ID: 21348790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral appliances in the treatment of oromandibular dystonia: a systematic review.
    De Meyer M; Vereecke L; Bottenberg P; Jacquet W; Sims AB; Santens P
    Acta Neurol Belg; 2020 Aug; 120(4):831-836. PubMed ID: 32594465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Blepharospasm and Oromandibular Dystonia with Botulinum Toxins.
    Hassell TJW; Charles D
    Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32331272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin in movement disorders.
    Papapetropoulos S; Singer C
    Semin Neurol; 2007 Apr; 27(2):183-94. PubMed ID: 17390263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin treatment in parkinsonism.
    Anandan C; Jankovic J
    J Neurol Sci; 2024 Jan; 456():122810. PubMed ID: 38056063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of focal dystonia with botulinum toxin A].
    Sojer M; Wissel J; Müller J; Poewe W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin for the treatment of movement disorders.
    Thenganatt MA; Fahn S
    Curr Neurol Neurosci Rep; 2012 Aug; 12(4):399-409. PubMed ID: 22661378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of movement disorders using botulinum toxin].
    Burgunder JM
    Schweiz Med Wochenschr; 1992 Sep; 122(36):1311-6. PubMed ID: 1411387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum neurotoxin a therapy efficacy and safety for oromandibular dystonia: a meta-analysis.
    Dadgardoust PD; Rosales RL; Asuncion RM; Dressler D
    J Neural Transm (Vienna); 2019 Feb; 126(2):141-148. PubMed ID: 30604200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations.
    Bhidayasiri R; Cardoso F; Truong DD
    Eur J Neurol; 2006 Feb; 13 Suppl 1():21-9. PubMed ID: 16417594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.